Omeros last closed at $18.90 (+1.56%) on 2026-10-05. Signals today: Death cross. Listed on Nasdaq. Trailing 12 months PER is 13.6×. Its overall grade ranks 50 of 741 stocks in Healthcare.
About this company
Omeros last closed at $18.90 (+1.56%) on 2026-10-05. Signals today: Death cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 50/741
Valuation grade F
Related stocks
- AmgenCompetitor
희귀질환·염증/면역질환 치료제 개발에서 경쟁하는 대형 바이오 기업
- Alexion PharmaceuticalsCompetitor
보체계 질환·희귀질환 치료제 영역에서 Omeros와 유사한 경쟁 구도
- RocheCompetitor
면역·혈액질환 및 희귀질환 치료제 파이프라인에서 간접 경쟁
ETFs holding this stock
Invesco Dynamic BioTech & Genome ETF · Virtus LifeSci Biotech Products ETF · SPDR S&P Pharmaceuticals ETF
Details →About Omeros
- What technical signals does Omeros (OMER) have?
- Omeros current technical signals: death cross (5_20, 0d ago).
- Is Omeros a cup-and-handle pattern?
- No. Omeros has no valid Cup signal right now.
- What published figures are available for Omeros?
- Market cap: $1.34B. Trailing 12 months PER: 13.6×. Latest quarter PBR: -32.99×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Omeros, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.